Learn more

N GENE RES LAB INC

Overview
  • Total Patents
    102
  • GoodIP Patent Rank
    207,318
About

N GENE RES LAB INC has a total of 102 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are GENKYOTEX SUISSE SA, ERGONEX PHARMA GMBH and COLCA GERARD R.

Patent filings per year

Chart showing N GENE RES LAB INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Szilvassy Zoltan 44
#2 Takacs Kalman 34
#3 Literati Nagy Peter 34
#4 Tory Kalman 33
#5 Kolonics Attila 32
#6 Suemegi Balazs 30
#7 Egri Janos 27
#8 Vigh Laszlo 27
#9 Bernath Sandor 26
#10 Balogh Gabor 22

Latest patents

Publication Filing date Title
GB201421010D0 Method
US2009281143A1 Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity
CN101646439A Method of reduction of overweight or obesity
ZA200902761B A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect
US2008108673A1 Prevention and treatment of obesity
US2008108602A1 Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication
WO2007088446A2 A process and a reagent kit for the examination of the metabolic state related to the carbohydrate and lipid metabolism of a human organism
WO2006079910A2 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity
HU0401282D0 Pharmaceutical composition containing optically active o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxim
HU0401176D0 Pharmaceutical composition having prpkinetic effect
HU0401177D0 Pharmaceutical composition for increasing the mitochondrial genesis
AU2003278514A1 Use of a thiazolidinedione for the reduction of side effects of chemotherapy
WO03007951A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes
HU0202204D0 Pharmaceutical combination for the prophylaxis or treatment of diabetes
US6884424B2 Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
HU0102982D0 Synergic pharmaceutical composition
SK13502002A3 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
UA73557C2 Amideoxyme derivatives of propenecarboxylic acid, a method for the preparation thereof and a pharmaceutical composition based thereon
HU0100987D0 New propenecarboxylic acid amidoxime derivatives, process for their preparation and pharmaceutical compositions containing them
AU6180399A A cosmetic composition and a method for reducing the ageing processes of skin